| Application no. and date | 11701392.0 (espacenet) (Federated) (European Patent Register), 20110121 | | Patent/reg. no. and date | DK/EP 2525796, 20160330 | | Publication date | 20121128 | | Priority no. and date | EP 10151326, 20100121, US 296964 P, 20100121 | | EP pub. no. and date |
EP 2525796 20121128 | | Effective date | | | Applicant/owner | APREA AB, Nobels väg 3
171 65 Solna, SE | | Applicant ref. no. | P58887dk01 | | Inventor | CARAM-LELHAM, Ninus, Tiundagatan 61
S-752 30 Uppsala, SE,
BYSTRÖM, Styrbjörn, HedÃ¥svägen 1
S-187 36 Täby, SE,
LILJEBRIS, Charlotta, Torpkällevägen 33
S-741 96 Knivsta, SE | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | | Opponent | | | IPC Class | A61K 31/439 (2006.01) , A61K 45/06 (2006.01) , A61K 9/08 (2006.01) , A61P 35/00 (2006.01) , A61P 9/00 (2006.01) | | Title | Vandig opløsning omfattende 3-quinuclidinoner til behandlingen af hyperproliferativ sygdom, autoimmun sygdom og hjertesygdom | | Int. application no. | EP2011050854 | | Int. publication no. | WO2011089234 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
